NYSE:GME
NYSE:GMESpecialty Retail

GameStop (GME) Net Margin Breakout Tests Bullish Profitability Narratives Heading Into Q3 2026

GameStop (GME) opened Q3 2026 with momentum behind it, coming off Q2 revenue of $972 million and basic EPS of $0.38 alongside net income of $168.6 million, with trailing twelve month EPS reaching $0.81 on revenue of about $3.8 billion and net income of $362.2 million. The company has seen quarterly revenue move from $798 million in Q2 2025 to $972 million in Q2 2026, while basic EPS climbed from $0.04 to $0.38 over the same stretch, setting the stage for investors to focus on how these...
ENXTPA:MEDCL
ENXTPA:MEDCLPharmaceuticals

MedinCell (ENXTPA:MEDCL): Assessing Valuation After Teva’s FDA Filing for Olanzapine Long-Acting Injectable

MedinCell (ENXTPA:MEDCL) has been in focus after partner Teva filed a New Drug Application with the U.S. FDA for its olanzapine long acting injectable, which is built on MedinCell’s BEPO technology. See our latest analysis for MedinCell. The latest regulatory milestone appears to have reignited interest in MedinCell, with the 1 day share price return of 3.85 percent and a 90 day share price return of 41.39 percent contributing to a robust 1 year total shareholder return of 77.19 percent. This...
XTRA:DHER
XTRA:DHERHospitality

Delivery Hero (XTRA:DHER) Is Up 21.8% After Launching Strategic Review Of Portfolio And Capital Allocation – Has The Bull Case Changed?

Delivery Hero recently confirmed that it is reviewing capital allocation and exploring options such as partnerships, asset sales, and other structural moves after large shareholders criticized its financial performance and portfolio strategy, following an approximate 53% share price drop over the past year that left the group valued at about €5.20 billion (US$6.10 billion). An important wrinkle is that investors and potential industry buyers are said to be particularly interested in...